Innovating healthcare for everyone
Sanofi (proventionbio.com) scores 76 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 51st percentile of 17552 Healthcare brands.
Sanofi is a global pharmaceutical company headquartered in Paris, founded in 2004. It develops and provides healthcare solutions and treatments, including addressing infectious diseases and patient advocacy, aiming to improve patient access and care worldwide. The company serves patients, healthcare providers, policymakers, and communities, positioning itself as a research-driven innovator committed to expanding access to advanced medical treatments through science and collaboration.
| Brand Name | Sanofi |
|---|---|
| Domain | proventionbio.com |
| Industry | Healthcare |
| Founded | 2004 |
| Headquarters | Paris |
| Parent Company / Owner | L'Oréal |
| CEO | Paul Hudson |
| Main Competitors | Pfizer (89/100), Novartis (71/100), Roche (81/100), Merck & Co. (81/100), GlaxoSmithKline (83/100), AstraZeneca (82/100), Johnson & Johnson (87/100), Bayer (77/100) |
Moz Domain Authority 36/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,674,669 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments." (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, YouTube, Instagram; no detected presence on Facebook, X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Sanofi?", Claude could identify the brand as of October 2026. Provention Bio was a biopharmaceutical company that developed Tzield (teplizumab), the first FDA-approved therapy to delay the onset of clinical type 1 diabetes, and it was acquired by Sanofi in 2023 to bolster Sanofi's immunology pipeline. Best known for Developing Tzield (teplizumab), the first approved drug to delay type 1 diabetes onset.
When asked "Best brands similar to Sanofi?", Claude would recommend Sanofi as of October 2026. It's relevant when discussing innovative immunology or diabetes-prevention therapies and Sanofi's expansion in that space through acquisition.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Sanofi's main competitors in Healthcare: Pfizer (89/100), Novartis (71/100), Roche (81/100), Merck & Co. (81/100), GlaxoSmithKline (83/100).
Sources: Brand Analyzer scan
Sanofi has limited AI-search visibility, scoring 33/100 on Brand Analyzer's AI visibility composite (visibility 25, trust 33, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Sanofi official site
Sanofi was founded in 2004. Sanofi operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Sanofi is headquartered in Paris. Sanofi operates in the Healthcare category.
Sources: Wikidata
Sanofi scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Sanofi official site
Sanofi is a global pharmaceutical company headquartered in Paris, France. It was founded in 2004 and operates in the healthcare sector, developing treatments and solutions aimed at improving patient outcomes worldwide.
Sources: Sanofi official site
Sanofi can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Sanofi official site
Sanofi is owned by or part of L'Oréal. Sanofi operates in the Healthcare category.
Sources: Wikidata
Sanofi develops, manufactures, and markets pharmaceutical products and treatments across various therapeutic areas, including infectious diseases. The company focuses on innovative healthcare solutions designed to improve patient access and care, working with healthcare providers, policymakers, and communities to address critical health challenges.
Sources: Sanofi official site
Sanofi's offerings are used by patients, healthcare providers, policymakers, and communities seeking advanced medical treatments and improved healthcare access. The company engages with these groups to address critical health challenges and expand access to care.
Sources: Sanofi official site
Sanofi scores 33/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Sanofi has a weak AI-visibility profile at 33/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (25/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,674,669 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 36/100 and thin schema.org structured data. In a live check, Claude could already identify Sanofi from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Sanofi: Propel Physiotherapy (76/100), Prometteur Solutions (76/100), Prudential plc (76/100), Pru Life UK (76/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.